A urinary biomarker profile for children with HIV-associated renal diseases

Angel A Soler-García1, Natella Y Rakhmanina, Parnell C Mattison

  • 1Center for Molecular Physiology Research, Division of Nephrology, Children's National Medical Center, Children's Research Institute, Washington, District of Columbia 20010, USA.

Kidney International
|April 10, 2009
PubMed

Insights

Biomarkers in urine may help diagnose kidney disease in children with human immunodeficiency virus (HIV). Lower epidermal growth factor and higher fibroblast growth factor-2 and metalloproteinase-2 levels indicate risk for HIV-associated nephropathy (HIVAN).

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Biomarker Discovery

Background:

  • Children with human immunodeficiency virus (HIV) are susceptible to renal diseases, notably HIV-associated nephropathy (HIVAN).
  • HIVAN diagnosis typically requires renal biopsy, a risky procedure for immunocompromised children.
  • Identifying non-invasive biomarkers is crucial for early detection and management of HIVAN in pediatric populations.

Purpose of the Study:

  • To identify urinary growth factor biomarkers predictive of renal lesions in HIV-infected children.
  • To assess the potential of these biomarkers for diagnosing HIVAN and its severity.

Main Methods:

  • Analyzed urinary growth factor levels (epidermal growth factor, fibroblast growth factor-2, metalloproteinase-2) in 55 HIV-infected children.
  • Correlated biomarker levels with the presence and extent of renal disease.
  • Validated findings in a mouse model (HIV-Tg26) of HIVAN.

Main Results:

  • Lower urinary epidermal growth factor levels were observed in children with renal disease.
  • Higher urinary fibroblast growth factor-2 and metalloproteinase-2 levels were found in children with renal disease.
  • Similar biomarker changes were noted in HIV-Tg26 mice, correlating with disease progression.

Conclusions:

  • A specific urinary growth factor profile may aid in diagnosing HIVAN in at-risk children.
  • These biomarkers could facilitate earlier detection and intervention for HIV-related kidney disease.
  • Non-invasive biomarker assessment offers a promising alternative to renal biopsy in certain clinical scenarios.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...